MediFind found 7 doctor with experience in Anti-NMDA Receptor Encephalitis near Liaoning, CN. Of these, 7 are Experienced.
Xiuli Shang practices in Shenyang, China. Shang is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Subacute Combined Degeneration, Vitamin B12 Deficiency Anemia, Stroke, and Creutzfeldt-Jakob Disease.
Xiaoguang Luo practices in Shenyang, China. Luo is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Cerebellar Multiple System Atrophy, Multiple System Atrophy, Parkinson's Disease, and Movement Disorders.
Cheng Xia practices in Shenyang, China. Mr. Xia is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. His top areas of expertise are CACH Syndrome, Intestinal Pseudo-Obstruction, Pustules, and Encephalitis.
Hui-sheng Chen-Zhou practices in Shenyang, China. Chen-Zhou is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Stroke, Atherosclerosis, Anti-NMDA Receptor Encephalitis, and Thrombectomy.
Zhanhua Liang practices in Dalian, China. Liang is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Parkinson's Disease, Movement Disorders, Benign Essential Blepharospasm, Deep Brain Stimulation, and Microvascular Decompression.
Yu-lung Lau practices in Hong Kong, China. Lau is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are X-Linked Agammaglobulinemia, Chronic Granulomatous Disease, Severe Combined Immunodeficiency (SCID), and Flu.
Kun Zhou practices in Shenyang, China. Zhou is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Lung Cancer, Esophageal Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Endoscopy.
Last Updated: 01/09/2026